Effect of in utero exposure to beta-2 adrenergic receptor agonists and selective serotonin reuptake inhibitors on the risk for autism spectrum disorders

2021 ◽  
Author(s):  
Nicole Bondad Gidaya
Keyword(s):  
Autism Spectrum Disorders ◽  
Adrenergic Receptor ◽  
Serotonin Reuptake ◽  
Selective Serotonin Reuptake Inhibitors ◽  
In Utero ◽  
Autism Spectrum ◽  
Serotonin Reuptake Inhibitors ◽  
In Utero Exposure ◽  
Beta 2 ◽  
Spectrum Disorders

In utero Exposure to  -2-Adrenergic Receptor Agonist Drugs and Risk for Autism Spectrum Disorders

PEDIATRICS ◽  
2016 ◽  
Vol 137 (2) ◽  
pp. e20151316-e20151316 ◽  
Author(s):  
N. B. Gidaya ◽  
B. K. Lee ◽  
I. Burstyn ◽  
Y. Michael ◽  
C. J. Newschaffer ◽  
...  
Keyword(s):  
Autism Spectrum Disorders ◽  
Adrenergic Receptor ◽  
Receptor Agonist ◽  
In Utero ◽  
Autism Spectrum ◽  
In Utero Exposure ◽  
Spectrum Disorders ◽  
Adrenergic Receptor Agonist
Sign in / Sign up

Export Citation Format

Share Document